Cargando...
Neprilysin inhibition: a new therapeutic option for type 2 diabetes?
Neprilysin is a widely expressed peptidase with broad substrate specificity that preferentially hydrolyses oligopeptide substrates, many of which regulate the cardiovascular, nervous and immune systems. Emerging evidence suggests that neprilysin also hydrolyses peptides that play an important role i...
Guardado en:
| Publicado en: | Diabetologia |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6579747/ https://ncbi.nlm.nih.gov/pubmed/31089754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-019-4889-y |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|